Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.075 EUR | +0.30% | +1.78% | +30.80% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 03 | AIB buys back EUR999 million worth of shares from Irish government | AN |
Sales 2024 * | 4.56B 4.94B | Sales 2025 * | 4.34B 4.71B | Capitalization | 12.25B 13.28B |
---|---|---|---|---|---|
Net income 2024 * | 1.76B 1.91B | Net income 2025 * | 1.56B 1.69B | EV / Sales 2024 * | 2.69 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.82 x |
P/E ratio 2024 * |
7.06
x | P/E ratio 2025 * |
7.34
x | Employees | 10,551 |
Yield 2024 * |
5.94% | Yield 2025 * |
6.3% | Free-Float | 67.6% |
Latest transcript on AIB Group plc
1 day | +0.30% | ||
1 week | +1.78% | ||
Current month | +4.30% | ||
1 month | +1.91% | ||
3 months | +20.32% | ||
6 months | +21.06% | ||
Current year | +30.80% |
Managers | Title | Age | Since |
---|---|---|---|
Colin Hunt
CEO | Chief Executive Officer | 54 | 15-12-31 |
Donal Galvin
DFI | Director of Finance/CFO | 50 | 13-08-31 |
Graham Fagan
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fergal O’Dwyer
BRD | Director/Board Member | 64 | 21-01-21 |
James Pettigrew
CHM | Chairman | 65 | 21-10-27 |
Brendan McDonagh
BRD | Director/Board Member | 66 | 16-10-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 3 M€ | +9.95% | - | |
0.21% | 5 M€ | +10.09% | - | |
0.21% | 14 M€ | +5.66% | - | |
0.10% | 33 M€ | +2.68% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 5.075 | +0.30% | 490 050 |
24-05-16 | 5.06 | +1.00% | 4,975,453 |
24-05-15 | 5.01 | +0.48% | 4,024,452 |
24-05-14 | 4.986 | +0.73% | 3,819,327 |
24-05-13 | 4.95 | -0.72% | 4,235,486 |
Real-time Irish S.E., May 17, 2024 at 05:22 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.80% | 13.31B | |
+19.04% | 583B | |
+16.53% | 307B | |
+23.30% | 254B | |
+24.08% | 213B | |
+25.81% | 191B | |
+29.53% | 172B | |
+9.22% | 164B | |
+7.70% | 150B | |
+8.26% | 137B |
- Stock Market
- Equities
- A5G Stock